Third Wave, Shimadzu, Toppan to Develop Point-of-Care Device for Avoiding ADRs

genomeweb
360dx

Third Wave, Shimadzu, Toppan to Develop Point-of-Care Device for Avoiding ADRs

Mar 02, 2006

NEW YORK, March 2 (GenomeWeb News) - Third Wave Technologies, Shimadzu, and Toppan Printing plan to co-develop and commercialize a point-of-care device that aims to prevent adverse drug reactions, the companies said today.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Recessive Mutation May Cause New Neurodevelopmental Disorder
Bird, Reptile DNA Sequences Used to Reconstruct Genome of Dinosaur Ancestor
Envisagenics Wins $1.5M NIH Grant to Advance Alternative Splicing Analysis Tech
Grail Raises $300M in Series C Round
Qiagen, HTG Molecular End First Project Under CDx Development Agreement
Cytox, Mayo Clinic Team Up to Study Alzheimer's Disease Assays

The Scan

Testing, Testing for Mutations

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

Hide, Nessie, Hide

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

Even More Variety

The New York Times writes about the appearance of mosaicism in healthy people.

This Week in PNAS

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Main menu